

Tesamorelin 20 MG
Stabilized growth hormone-releasing factor (GHRH) analog with hexenoyl modification for visceral adipose research.
Available to order
### Stabilized GHRH Analog for Metabolic & Visceral Adipose Research
Tesamorelin (20 MG) is a synthetic 44-amino acid peptide analogue of human growth hormone-releasing factor (GHRH 1-44) modified with a trans-3-hexenoic acid group at the N-terminal tyrosine.
This structural stabilization enhances enzymatic resistance to dipeptidyl peptidase-4 (DPP-4) degradation while retaining full receptor potency.
### Primary Research Applications
• **Visceral Adipose Tissue**: Evaluated in visceral lipolysis kinetics and abdominal adipocyte lipid mobilization.
• **Pituitary Somatotropic Axis**: Studied for sustained GHRH receptor signaling without receptor desensitization.
• **Hepatic Lipid Markers**: Examined in non-alcoholic fatty liver cellular models and triglyceride turnover.
### Chemical Specifications
• **Molecular Formula**: C221H366N72O67S
• **Molecular Weight**: ~5135.8 g/mol
• **Purity**: ?98.5% (RP-HPLC)
• **Form**: Sterile Lyophilized White Cake
• **Counterion**: Acetate
### Storage Recommendations
• Keep sealed vial at -20??C in dark storage.
• Once reconstituted with Bacteriostatic Water, store at 2??C to 8??C and use within 21 days.
Certificate of Analysis (CoA)
Lot-specific analytical documentation verified via Reverse-Phase HPLC and Mass Spectrometry for Tesamorelin 20 MG. Confirms purity, sequence identity, and laboratory-grade compliance.


